Indications
Therapeutic Asset Ratings
18,134 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Raltitrexed
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
P3
BB
(65)
Ranitidine
Plasma Cell Myeloma
Hoffmann-La Roche
P3
BB
(65)
Resiniferatoxin
Osteoarthritis, Knee
Sorrento Therapeutics, Inc.
P3
BB
(65)
Rezivertinib
Non-Small Cell Lung Carcinoma
The First Affiliated Hospital of Guangzhou Medical University
P3
BB
(65)
Rivaroxaban
Migraine Disorder
Chinese Academy of Medical Sciences, Fuwai Hospital
P3
BB
(65)
Rivoceranib
Chemotherapy-Induced Toxicity
Linhui Peng
P3
BB
(65)
Romidepsin
T-Cell Non-Hodgkin Lymphoma
Sichuan University
P3
BB
(65)
Sonrotoclax
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer Center
P3
BB
(65)
Sorafenib
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
The First Affiliated Hospital of Soochow University
P3
BB
(65)
Sorafenib
Cutaneous Melanoma
National Cancer Institute (NCI)
P3
BB
(65)
Sorafenib
Acute Lymphoblastic Leukemia
Nanfang Hospital, Southern Medical University
P3
BB
(65)
Sulfamethoxazole
Plasma Cell Myeloma
Monash University
P3
BB
(65)
Thalidomide
Chemotherapy-Induced Toxicity
Fudan University
P3
BB
(65)
Tirofiban
Cerebral Infarction
Weifang Medical University
P3
BB
(65)
Trazodone
Depressive Disorder
Centre Hospitalier St Anne
P3
BB
(65)
Tretinoin
Non-Small Cell Lung Carcinoma
Peking University People's Hospital
P3
BB
(65)
Tucidinostat
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Xiamen University
P3
BB
(65)
Vidofludimus
Relapsing-Remitting Multiple Sclerosis
Immunic AG
P3
BB
(65)
(+)-Vincristine
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(65)
Vinorelbine Ditartrate
Breast Neoplasm
Sun Yat-sen University
P3
BB
(65)
Vinorelbine Ditartrate
Her2-Receptor Negative Breast Cancer
Wang Jiayu
P3
BB
(65)
Volitinib
Papillary Renal Cell Carcinoma
AstraZeneca
P3
BB
(65)
Volitinib
Non-Small Cell Lung Carcinoma
Qingdao Central Hospital
P3
BB
(65)
Zanubrutinib
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
SWOG Cancer Research Network
P3
BB
(65)
Zanzalintinib
Hepatocellular Carcinoma
Exelixis
P3
BB
(65)
Showing 3951 to 3975 of 18,134 assets
Previous
Page 159 of 726
Next